Livelyhood

Livelyhood

The Gut Punch Weekly #6

Hims slams pharma in Super Bowl ad, most GLP-1 patients discontinue treatment, exenatide fails to treat Parkinson's, PepsiCo shifts to healthier snacking, and more!

Feb 05, 2025
∙ Paid
User's avatar

Continue reading this post for free, courtesy of Lance Lively.

Or purchase a paid subscription.
© 2026 Lance Lively · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture